Skip to main content
Contact Us
Subscribe
E-Edition
95°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tela Bio Inc
(NQ:
TELA
)
4.700
-0.440 (-8.56%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Tela Bio Inc
< Previous
1
2
Next >
TELA Bio Announces Pricing of Public Offering of Common Stock
April 18, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Proposed Public Offering of Common Stock
April 18, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio’s OviTex® Reinforced Tissue Matrix to be Featured in Three Case Reports at SAGES 2023
March 29, 2023
Presentations highlight utility of this advanced hernia reinforcement material for robotic procedures
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces 510(k) Clearance for OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
March 23, 2023
Company continues design advancements of biologic-based materials for soft tissue repair and reinforcement
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Reports Fourth Quarter and Full Year 2022 Financial Results
March 21, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Highlights Published Clinical Research from 2022 Showcasing Safety and Performance of Reinforced Biologic for Hernia Indications
March 16, 2023
Recent research of OviTex® Reinforced Tissue Matrix demonstrated favorable results in various hernia and abdominal wall reconstruction applications
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce Fourth Quarter and Full Year 2022 Financial Results
February 28, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 24, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces U.S. Commercial Launch of Two New OviTex® LPR Device Configurations to Repair Large Abdominal Hernias Using Robotic and Laparoscopic Techniques
February 21, 2023
Company continues to expand innovative product portfolio to address surgeon needs
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Awarded Biosynthetic Mesh Products Agreement with a National Group Purchasing Organization
February 14, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 20, 2023
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces U.S. Commercial Launch of NIVIS™ Fibrillar Collagen Pack, The Natural Restoration Solution to Support Healing of Surgical Wounds
January 09, 2023
Company grows product portfolio, expanding product offerings to optimize soft tissue preservation and restoration
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in the 41st Annual J.P. Morgan Healthcare Conference
December 21, 2022
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 09, 2022
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in Piper Sandler 34th Annual Healthcare Conference
November 21, 2022
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Reports Third Quarter 2022 Financial Results
November 09, 2022
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Participate in Canaccord MedTech, Diagnostics and Digital Health & Services Forum
November 03, 2022
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 28, 2022
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce Third Quarter 2022 Financial Results
October 27, 2022
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio Announces Publication of 24-Month BRAVO Study Results Demonstrating Benefits of OviTex® Reinforced Tissue Matrix in Hernia Repair
October 26, 2022
Study results show a low 2.6% recurrence rate and clinically meaningful improvement in patient quality of life
From
TELA Bio, Inc.
Via
GlobeNewswire
TELA Bio to Announce Second Quarter 2022 Financial Results
July 27, 2022
From
TELA Bio, Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.